SICK SINUS SYNDROME: AN ADENOSINE- MEDIATED DISEASE
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial
Adenosine monophosphate for postherpetic neuralgia.